Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases

NANot yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Obesity and OverweightPre-diabeticType 2 Diabetes Mellitus (T2DM)
Interventions
OTHER

Optimal Metabotype-specific diet

Following screening, baseline measurements, and determination of Metabotype, participants will be randomly assigned, using minimisation, to either the Precision Nutrition (PN) group or the Control (CN) group. The PN group will receive a diet hypothesised to be optimal for their specific Metabotype. All participants will adhere to their assigned diets for 12 months. Each Metabotype-specific diet will align with the Dutch Healthy Dietary Guidelines, while varying in macronutrient composition and quality.

OTHER

Sub-optimal diet

Participants randomised to the Control Group (CN), will be randomly assigned one of the two diets optimised for a different Metabotype of the same sex. The assigned CN Group diet will always have a macronutrient content and quality that is different than their hypothesised optimal diet. All diets will align with the Dutch Healthy Dietary Guidelines.

Trial Locations (2)

6200MD

Maastricht University Medical Center, Department of Human Biology, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht

6700AA

Wageningen University and Research, Division of Human Nutrition, Wageningen

Sponsors
All Listed Sponsors
collaborator

Wageningen University and Research

OTHER

collaborator

Health Holland

OTHER

collaborator

TKI Agri & Food

UNKNOWN

collaborator

Nestle Health Science

INDUSTRY

collaborator

Beneo GmbH

INDUSTRY

collaborator

BARILLA G. e R. Fratelli S.p.A., Parma, Italy

UNKNOWN

lead

Maastricht University Medical Center

OTHER

NCT06923644 - Targeted Precision Nutrition Strategy To Prevent Chronic Metabolic Diseases | Biotech Hunter | Biotech Hunter